Sonoma Pharmaceuticals's total assets for Q2 2025 were $13.69M, an increase of 0.09% from the previous quarter. SNOA total liabilities were $8.33M for the fiscal quarter, a -4.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.